Understanding Phase I Clinical Trials
Phase I clinical trials mark the first time a potential new therapy or drug candidate is administered to human volunteers. Whereas preclinical studies in cells and animals reveal preliminary safety and efficacy, Phase I transitions into humans with the core aim of establishing an initial safety profile. These trials typically enroll between 20 and 80 […]
Innovations Driving Medical Research Today
The landscape of clinical research is evolving rapidly thanks to technological breakthroughs. Innovations that were once futuristic—like artificial-intelligence-driven predictive models or continuous remote monitoring—are now integral to how trials are designed, conducted, and analyzed.
Ensuring Patient Safety in Early-Stage Studies
Patient safety is the non-negotiable cornerstone of any clinical trial, but it becomes especially critical in Phase I and II studies, where novel interventions carry unknown risks. A robust safety framework not only protects participants but also builds credibility with regulators and the scientific community Core Safety Practices Enhancing Transparency and Trust Benefits of a […]